Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Barbara Ann Karmanos Cancer Institute
University of Southampton
National Institutes of Health Clinical Center (CC)